Latest Insider Transactions at Adaptive Biotechnologies Corp (ADPT)
This section provides a real-time view of insider transactions for Adaptive Biotechnologies Corp (ADPT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Adaptive Biotechnologies Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Adaptive Biotechnologies Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2021
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
5,255
-0.15%
|
$204,945
$39.15 P/Share
|
|
Jun 16
2021
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
4,745
-0.27%
|
$180,310
$38.13 P/Share
|
|
Jun 15
2021
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
20,000
-0.57%
|
$760,000
$38.73 P/Share
|
|
Jun 14
2021
|
R Mark Adams Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
8,914
-13.3%
|
$338,732
$38.77 P/Share
|
|
Jun 14
2021
|
Michelle Renee Griffin Director |
SELL
Open market or private sale
|
Direct |
2,500
-62.44%
|
$95,000
$38.56 P/Share
|
|
Jun 14
2021
|
Michelle Renee Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+38.44%
|
$17,500
$7.8 P/Share
|
|
Jun 11
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,895
-5.32%
|
$148,010
$38.41 P/Share
|
|
Jun 11
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,895
+5.05%
|
$23,370
$6.32 P/Share
|
|
Jun 10
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,895
-2.69%
|
$144,115
$37.32 P/Share
|
|
Jun 10
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,895
+5.05%
|
$23,370
$6.32 P/Share
|
|
Jun 09
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,895
-2.68%
|
$140,220
$36.21 P/Share
|
|
Jun 09
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,895
+5.05%
|
$23,370
$6.32 P/Share
|
|
Jun 09
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-31.64%
|
$350,000
$35.6 P/Share
|
|
Jun 09
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+24.04%
|
$60,000
$6.55 P/Share
|
|
Jun 08
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-16.74%
|
$370,000
$37.38 P/Share
|
|
Jun 08
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+24.04%
|
$60,000
$6.55 P/Share
|
|
May 18
2021
|
Jyoti Palaniappan SVP, Diagnostics, T-Detect |
SELL
Open market or private sale
|
Direct |
651
-6.64%
|
$22,785
$35.0 P/Share
|
|
May 18
2021
|
Jyoti Palaniappan SVP, Diagnostics, T-Detect |
BUY
Exercise of conversion of derivative security
|
Direct |
651
+6.22%
|
$14,322
$22.55 P/Share
|
|
May 18
2021
|
Michelle Renee Griffin Director |
SELL
Open market or private sale
|
Direct |
2,500
-62.44%
|
$87,500
$35.0 P/Share
|
|
May 18
2021
|
Michelle Renee Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+38.44%
|
$17,500
$7.8 P/Share
|
|
May 17
2021
|
Henning Thorsen SVP, Commercial Operations |
BUY
Grant, award, or other acquisition
|
Direct |
29,061
+50.0%
|
-
|
|
May 14
2021
|
Francis Lo Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,000
-8.85%
|
$66,000
$33.8 P/Share
|
|
May 14
2021
|
Francis Lo Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+8.13%
|
$14,000
$7.8 P/Share
|
|
May 12
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-31.64%
|
$320,000
$32.63 P/Share
|
|
May 12
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+24.04%
|
$60,000
$6.55 P/Share
|
|
May 11
2021
|
Chad M Cohen Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,000
-16.97%
|
$310,000
$31.33 P/Share
|
|
May 11
2021
|
Chad M Cohen Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+24.04%
|
$60,000
$6.55 P/Share
|
|
May 06
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,895
-2.68%
|
$136,325
$35.95 P/Share
|
|
May 06
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,895
+5.05%
|
$23,370
$6.32 P/Share
|
|
May 05
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,195
-4.4%
|
$111,825
$35.43 P/Share
|
|
May 05
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,895
+5.05%
|
$23,370
$6.32 P/Share
|
|
May 04
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,895
-2.68%
|
$140,220
$36.4 P/Share
|
|
May 04
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,895
+5.05%
|
$23,370
$6.32 P/Share
|
|
Apr 30
2021
|
Stacy L Taylor SVP and General Counsel |
SELL
Open market or private sale
|
Direct |
4,166
-21.7%
|
$170,806
$41.93 P/Share
|
|
Apr 30
2021
|
Stacy L Taylor SVP and General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
4,166
+7.23%
|
$62,490
$15.35 P/Share
|
|
Apr 22
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,790
-5.18%
|
$334,970
$43.22 P/Share
|
|
Apr 22
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,790
+9.17%
|
$46,740
$6.32 P/Share
|
|
Apr 21
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
7,790
-3.45%
|
$311,600
$40.94 P/Share
|
|
Apr 21
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,790
+9.17%
|
$46,740
$6.32 P/Share
|
|
Apr 20
2021
|
Harlan S Robins Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
11,685
-7.43%
|
$467,400
$40.8 P/Share
|
|
Apr 20
2021
|
Harlan S Robins Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,685
+12.6%
|
$70,110
$6.32 P/Share
|
|
Apr 19
2021
|
Jyoti Palaniappan SVP, Diagnostics, T-Detect |
SELL
Open market or private sale
|
Direct |
1,301
-12.44%
|
$53,341
$41.25 P/Share
|
|
Apr 19
2021
|
Jyoti Palaniappan SVP, Diagnostics, T-Detect |
BUY
Exercise of conversion of derivative security
|
Direct |
1,301
+11.06%
|
$28,622
$22.55 P/Share
|
|
Apr 15
2021
|
Francis Lo Chief People Officer |
SELL
Open market or private sale
|
Direct |
2,000
-8.85%
|
$86,000
$43.04 P/Share
|
|
Apr 15
2021
|
Francis Lo Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+8.13%
|
$14,000
$7.8 P/Share
|
|
Apr 14
2021
|
Michelle Renee Griffin Director |
SELL
Open market or private sale
|
Direct |
4,500
-74.95%
|
$193,500
$43.41 P/Share
|
|
Apr 14
2021
|
Michelle Renee Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+42.84%
|
$31,500
$7.8 P/Share
|
|
Apr 14
2021
|
Lance Baldo Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,000
-8.03%
|
$88,000
$44.5 P/Share
|
|
Apr 14
2021
|
Lance Baldo Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+7.44%
|
$14,000
$7.8 P/Share
|
|
Apr 08
2021
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
5,000
-0.1%
|
$210,000
$42.94 P/Share
|